Assembly Biosciences(ASMB)
Focus: Assembly Biosciences is a public biotech company focused on small-molecule antivirals for infectious diseases and neurology, with a lean 51-200 person team headquartered in South San Francisco. The company is in early-to-mid stage clinical development with no approved products.
Profile data last refreshed 12h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
2-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Assembly Biosciences?
AI assessmentAssembly is a high-risk, high-reward play for scientists who want early clinical involvement in antivirals but must tolerate acute cash constraints and execution uncertainty.
Why Work Here
- Focused antiviral pipeline with multiple hepatitis B programs (vebicorvir, ABI-H2158, ABI-H0731) in Phase 2 trials offering near-term clinical catalysts
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
17 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$29M
Pipeline & Clinical Trials
Quality Improvement
Type 2 Diabetes MellitusVideo-based Task-specific Training
StrokeClinical Trials (1)
Help build intelligence for Assembly Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.